Obiettivo
Traditional preclinical discovery methods, particularly for target validation, poorly predict drug efficacy, causing a high attrition rate in costly late-stage clinical trials. The PREDECT consortium will focus on complex but transferable, next generation in vitro and in vivo models for breast, prostate and lung cancers. Models will be investigated for their improved potential to validate novel therapeutic targets. Known targets, in canonical pathways, will be interrogated for induction of phenotypic, proteomic and transcriptomic changes using inhibitors. A strategy of seeking a ‘dynamic reciprocity’ of concordance between the steady and perturbed states of in vitro complex cultures, tissue slices and in vivo tumour models will be pursued by systems biology analyses. Comparison with historic gene expression and genomic data from relevant clinical materials should permit the emergence of faithful models for target validation and beyond.
PREDECT is coordinated by Servier and AstraZeneca, and the managing entity of IMI JU funding is the University of Helsinki. The team assembles world-class biologists, clinicians and computational scientists from 8 prestigious EU institutes, 3 SMEs and 8 EFPIA members to develop and critically assess models for target validation. The interaction between pharmaceutical and academic participants will be proactive, through postdoc co-supervision and work package co-piloting.
We propose to develop and generate a repository of advanced complex models in 3 complementary areas: (i) in vitro 2D/3D organotypic (co-)cultures, stirred bioreactor aggregates and tissue slice systems; (ii) novel (orthotopic) grafts of human and mouse tumour samples; and (iii) genetically-engineered and mosaic mouse models. The deliverables of PREDECT are expected to shift paradigms in target validation, permitting greater predictivity of drug efficacy in patient cohorts.
Campo scientifico
Argomento(i)
Invito a presentare proposte
IMI-JU-02-2009
Vedi altri progetti per questo bando
Meccanismo di finanziamento
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinatore
91190 GIF-SUR-YVETTE
Francia
Mostra sulla mappa
Partecipanti (20)
00014 Helsingin Yliopisto
Mostra sulla mappa
Partecipazione conclusa
02044 VTT ESPOO
Mostra sulla mappa
1015 Lausanne
Mostra sulla mappa
7610001 Rehovot
Mostra sulla mappa
2781-901 Oeiras
Mostra sulla mappa
6525 XZ Nijmegen
Mostra sulla mappa
3015 GD Rotterdam
Mostra sulla mappa
51005 Tartu
Mostra sulla mappa
79108 Freiburg
Mostra sulla mappa
00290 Helsinki
Mostra sulla mappa
151 85 Sodertaelje
Mostra sulla mappa
13353 Berlin
Mostra sulla mappa
02200 Espoo
Mostra sulla mappa
4070 Basel
Mostra sulla mappa
Partecipazione conclusa
00144 Roma
Mostra sulla mappa
55218 Ingelheim
Mostra sulla mappa
70376 Stuttgart
Mostra sulla mappa
2340 Beerse
Mostra sulla mappa
CF24 0DE Cardiff
Mostra sulla mappa
60064 North Chicago Il
Mostra sulla mappa